Metabolic Syndrome. Metabolic syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: People who have 3 or more of the metabolic syndrome criteria Elevated Waist Circumference: Men>102cm ,Women >88cm Elevated Triglycerides =150mg/dl or on drug treatment Reduced HDL: Men<40 ,Women<50 or on drug treatment Elevated Blood Pressure: Systolic=130 and/or Diastolic=85 or on drug treatment Elevated Fasting Glucose = 100mg/dl or on drug treatment
Exclusion criteria
Exclusion criteria: Individuals who take blood sugar lowering medications Alcohol users Individuals with psychiatric conditions Individuals with musculoskeletal problems who are unable to exercise Individuals who are absent from more than two consecutive exercise sessions Individuals who are engaged in professional sport 40160 mg/dL along with cardiovascular disease risk LDL>190 Patients with ischemic heart disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver steatosis grade. Timepoint: First study and after completing 8 weeks of intervention. Method of measurement: Ultrasonography.;Carotid Intima-Media Thickness (CIMT). Timepoint: First study and after completing 8 weeks of intervention. Method of measurement: Ultrasoography.;Skeletal Muscle Mass. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Body Composition Analyzer.;Percent Body Fat. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Body Composition Analyzer.;Body Mass Index. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Body Composition Analyzer.;Waist/hip ratio. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Body Composition Analyzer.;Body Fat Mass. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Body Composition Analyzer.;Visceral Fat Level. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Body Composition Analyzer.;Lipid profile. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Blood Test.;Thyroid-Stimulating Hormone. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Blood Test.;Liver Function Test(s). Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Blood Test.;Fasting Blood Suger. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Blood Test.;Glycated Hemoglobin. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Blood Test.;Blood pressure. Timepoint: Firs study and after completing 8 weeks of intervention. Method of measurement: Blood Pressure Monitor. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences